Bradley Foster & Sargent Inc Nkarta, Inc. Transaction History

Bradley Foster & Sargent Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 26, 2021	SELL	$31.33 - $59.61 $313,174 - $595,861	-9,996 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$27.03 - $75.62 $29,733 - $83,182	-1,100 Reduced 9.91%	9,996 $614,000
Q3 2020 Oct 26, 2020	BUY	$23.52 - $47.9 $260,977 - $531,498	11,096 New	11,096 $334,000

129

66.5M

173K

20K

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $110M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

Get notified when there are updates to the investment portfolio of Bradley Foster & Sargent Inc, based on Form 13F filings with the SEC.

Stay updated on Bradley Foster & Sargent Inc with notifications on news.